Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Sachin, Bhagwat"'
Autor:
Satish Bhavsar, Shivaji Pawar, Sanjeev Joshi, Sunil Jadhav, Amit Mishra, Bharat Dond, Abhijeet K Kayastha, Ravindra Yeole, Prasad Deshpande, Sachin Bhagwat, Mahesh Patel
Publikováno v:
Results in Chemistry, Vol 7, Iss , Pp 101485- (2024)
Continuous evolution in bacterial strains confines utility of frontline antibacterial agents due to development of multiple resistance mechanisms. Especially gram-negative multidrug bacterial resistance is foremost important topic of concern. The cur
Externí odkaz:
https://doaj.org/article/7ab5721c3e5e416ba98ec8db2ec5cda9
Autor:
Satish Bhavsar, Tadiparthi Ravikumar, Sunil Gupta, Shivaji Pawar, Sanjay Dabhade, Abhijeet K. Kayastha, Prasad Deshpande, Ravindra Yeole, Manohar Nandanwar, Sachin Bhagwat, Mahesh Patel
Publikováno v:
Results in Chemistry, Vol 5, Iss , Pp 100757- (2023)
Ketolides are the fourth generation semisynthetic macrolides derived from erythromycin A, designed to address the limitations of currently available drug treatments including penicillins, macrolides and glycopeptides. Ketolides-the next generation ma
Externí odkaz:
https://doaj.org/article/b93c9d847a4e44f9afa5c287d96287e3
Autor:
Bhusnure, Omprakash Gadgeppa, Gholve, Sachin Bhagwat, Giram, Padmaja Sidram, Gaikwad, Abhimanu Vilas, Udumansha, Ubaidulla, Mani, Ganesh, Tae, Jang Hyun
Publikováno v:
In Journal of Drug Delivery Science and Technology August 2021 64
Autor:
Malligarjunan Rajavel, Vijay Kumar, Ha Nguyen, Jacob Wyatt, Steven H. Marshall, Krisztina M. Papp-Wallace, Prasad Deshpande, Satish Bhavsar, Ravindra Yeole, Sachin Bhagwat, Mahesh Patel, Robert A. Bonomo, Focco van den Akker
Publikováno v:
mBio, Vol 12, Iss 1 (2021)
Antibiotic resistance is a significant clinical problem. Developing novel antibiotics that overcome known resistance mechanisms is highly desired.
Externí odkaz:
https://doaj.org/article/4aa59e08d52045aea5cd17d19b97f5ff
Autor:
Satish Bhavsar, Ravikumar Tadiparthi, Sunil Gupta, Shivaji Pawar, Ravindra Yeole, Abhijeet K. Kayastha, Prasad Deshpande, Sachin Bhagwat, Mahesh Patel
Publikováno v:
Chemical Papers. 77:3629-3640
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2e58ddba256a590495c85e2db8198e5
https://doi.org/10.1007/s11696-023-02725-3
https://doi.org/10.1007/s11696-023-02725-3
Publikováno v:
Microbial Drug Resistance. 29:18-27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::694baa137c122afcedf8613f22703c41
https://doi.org/10.1089/mdr.2022.0119
https://doi.org/10.1089/mdr.2022.0119
Publikováno v:
Microbial drug resistance (Larchmont, N.Y.).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5bca5bbacd1f0486f5a94966ca50c50a
https://pubmed.ncbi.nlm.nih.gov/36346323
https://pubmed.ncbi.nlm.nih.gov/36346323
Autor:
Satish Bhawsar, Shivaji Pawar, Prasad Deshpande, Ravindra Yeole, Rajesh Chavan, Manohar Nandanwar, Sachin Bhagwat, Mahesh Patel
Publikováno v:
Bioorganicmedicinal chemistry letters. 71
Increased resistance to gram positive infections have highlighted the limitations of currently available drug treatments including penicillins, macrolides and glycopeptides. As an alternative to address these challenges; Linezolid, the first antibiot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51436d30ed71e06dcb978ad2a82de960
https://pubmed.ncbi.nlm.nih.gov/35680102
https://pubmed.ncbi.nlm.nih.gov/35680102
Autor:
Ravindra D. Yeole, Rajesh Chavan, Sachin Bhagwat, Nilesh Chavan, Mahesh Patel, V. S. Zope, Kiran R. Patil
Publikováno v:
Xenobiotica. 51:251-261
Nafithromycin is a next generation lactone ketolide antibiotic slated to enter phase III clinical development in India for the treatment of CABP as a shorter 800 mg-OD X3 day therapeutic regimen. N...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42b71f502b57d9f6f1908dde5676f5c2
https://doi.org/10.1080/00498254.2020.1839983
https://doi.org/10.1080/00498254.2020.1839983
Autor:
Rajesh Chavan, Mahesh Patel, Nilesh Chavan, V. S. Zope, Sachin Bhagwat, Javeed Shaikh, Kiran R. Patil, Ravindra D. Yeole
Publikováno v:
Xenobiotica. 50:1149-1157
WCK 771 (INN: levonadifloxacin) is a novel antibacterial agent belonging to benzoquinolizine subclass of fluoroquinolones which is under clinical development as a parenteral formulation and its pro...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e90b5e7bcc0024c1d66223d77b1e46b
https://doi.org/10.1080/00498254.2020.1756007
https://doi.org/10.1080/00498254.2020.1756007